Pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ajanta Pharma has informed that it enclosed details of voting results through remote e-voting and at the AGM on each of the resolutions set out in the notice; Consolidated Scrutinizer's Report dated 14th July 2021 on remote e-voting and at the AGM.
The above information is a part of company’s filings submitted to BSE.